Richard Peters
Chairman bei APREA THERAPEUTICS, INC.
Vermögen: 43 760 $ am 31.03.2024
Profil
Richard Peters was the founder of X4 Pharmaceuticals, Inc. (founded in 2014) and MedNav, Inc. (founded in 1997), where he held the title of Chief Executive Officer.
He was also the founder of PIC Therapeutics, Inc. (founded in 2016), where he served as a Director.
Dr. Peters is also the founder of Tellbio, Inc. Dr. Peters's current job is President, Chief Executive Officer & Director at Yumanity, Inc. He is also the Chairman at Pharming Group NV, Aprea Therapeutics, Inc., and Lead Independent Director at Kineta, Inc. Dr. Peters's former jobs include President, Chief Executive Officer & Director at Merrimack Pharmaceuticals, Inc., President, CEO, Secretary, Treasurer & Director at Yumanity Therapeutics, Inc., Director-Medical Affairs at Amgen, Inc., Senior Director at Onyx Pharmaceuticals, Inc., and Senior Vice President & Head-Global Rare Diseases at Genzyme Corp.
Dr. Peters's education includes a doctorate from Medical University of South Carolina and an undergraduate degree from College of Charleston.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMING GROUP NV
0,00% | 31.03.2024 | 27 504 ( 0,00% ) | 30 269 $ | 31.03.2024 |
APREA THERAPEUTICS, INC.
0,02% | 23.08.2023 | 1 029 ( 0,02% ) | 6 884 $ | 31.03.2024 |
KINETA, INC.
0,11% | 12.04.2023 | 12 585 ( 0,11% ) | 6 607 $ | 31.03.2024 |
Aktive Positionen von Richard Peters
| Unternehmen | Position | Beginn |
|---|---|---|
| APREA THERAPEUTICS, INC. | Chairman | 23.08.2023 |
| KINETA, INC. | Director/Board Member | 19.12.2022 |
| PHARMING GROUP N.V. | Chairman | 25.09.2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Chief Executive Officer | - |
Tellbio, Inc.
 Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Founder | - |
Ehemalige bekannte Positionen von Richard Peters
| Unternehmen | Position | Ende |
|---|---|---|
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Founder | 01.06.2022 |
| YUMANITY THERAPEUTICS | Chief Executive Officer | 01.01.2022 |
| MERRIMACK PHARMACEUTICALS, INC. | Chief Executive Officer | 28.06.2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2017 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Richard Peters
| Medical University of South Carolina | Doctorate Degree |
| College of Charleston | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| AMGEN INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| KINETA, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services MedNav, Inc. develops mobile health applications. | Technology Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Health Technology |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Health Technology |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
